AIMOVIG vs COBENFY

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 18, 2026·How we rate

Possible drug interaction. AIMOVIG and COBENFY are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AIMOVIG	COBENFY
Rating	72/100	New
Pharmacy pays	—	~$7.08 /30
Type	RX	RX
Active ingredient	ERENUMAB-AOOE	TROSPIUM CHLORIDE AND XANOMELINE TARTRATE
Manufacturer	Amgen Inc	Bristol-Myers
Dosage forms	Injectable, Solution	Capsule, Oral pellets, Kit
Drug class	—	—
Boxed warning	None	None

aimovig cobenfy

Rating

72/100

New

Pharmacy pays

—

~$7.08 /30

Type

Active ingredient

ERENUMAB-AOOE

TROSPIUM CHLORIDE AND XANOMELINE TARTRATE

Manufacturer

Amgen Inc

Bristol-Myers

Dosage forms

Injectable, Solution

Capsule, Oral pellets, Kit

Drug class

—

Boxed warning

None

Frequently asked questions

What is the difference between Aimovig and Cobenfy?

Aimovig contains Erenumab-Aooe, while Cobenfy contains Trospium Chloride and Xanomeline Tartrate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.